Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-25-000520
Filing Date
2025-01-24
Accepted
2025-01-24 12:33:15
Documents
56
Period of Report
2024-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR NOV 2024 AMENDMENT 1 cannabisbio_i10qa1-113024.htm   iXBRL 10-Q/A 575670
2 CERTIFICATION cannabis_ex31.htm EX-31 10862
3 CERTIFICATION cannabis_ex32.htm EX-32 3743
  Complete submission text file 0001683168-25-000520.txt   3307283

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cbih-20241130.xsd EX-101.SCH 28111
5 XBRL CALCULATION FILE cbih-20241130_cal.xml EX-101.CAL 38737
6 XBRL DEFINITION FILE cbih-20241130_def.xml EX-101.DEF 82421
7 XBRL LABEL FILE cbih-20241130_lab.xml EX-101.LAB 247457
8 XBRL PRESENTATION FILE cbih-20241130_pre.xml EX-101.PRE 199587
60 EXTRACTED XBRL INSTANCE DOCUMENT cannabisbio_i10qa1-113024_htm.xml XML 336545
Mailing Address 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036
Business Address 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036 214-733-0868
Cannabis Bioscience International Holdings, Inc. (Filer) CIK: 0001411057 (see all company filings)

EIN.: 844901229 | Fiscal Year End: 0531
Type: 10-Q/A | Act: 34 | File No.: 333-146758 | Film No.: 25552792
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)